These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 2829494)
21. Release of endothelium-associated proteins into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes. Myrup B; Yokoyama H; Kristiansen OP; Østergaard PB; Olivecrona T Diabet Med; 2004 Oct; 21(10):1135-40. PubMed ID: 15384962 [TBL] [Abstract][Full Text] [Related]
22. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. Rusnati M; Urbinati C; Presta M J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401 [TBL] [Abstract][Full Text] [Related]
23. The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site. Park M; Lee ST Biochem Biophys Res Commun; 1999 Nov; 264(3):730-4. PubMed ID: 10544000 [TBL] [Abstract][Full Text] [Related]
24. Chemistry of heparin and low molecular weight heparin. Nielsen JI; Ostergaard P Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458 [No Abstract] [Full Text] [Related]
25. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links. Mousa SA Semin Thromb Hemost; 2007 Jul; 33(5):524-33. PubMed ID: 17629850 [TBL] [Abstract][Full Text] [Related]
26. [Passage of commercial heparin and a low molecular weight fragment of heparin, CY 222, across the placenta of pregnant rabbits]. Doutremepuich C; Fantauzzi B; Masse A; Refauvelet J; Bousquet F; Toulemonde F; Quilichini R Pathol Biol (Paris); 1985 Jun; 33(6):677-9. PubMed ID: 3900887 [TBL] [Abstract][Full Text] [Related]
27. Capillary zone electrophoresis investigation of the interaction between heparin and granulocyte-colony stimulating factor. Liang A; He X; Du Y; Wang K; Fung Y; Lin B Electrophoresis; 2004 Mar; 25(6):870-5. PubMed ID: 15004848 [TBL] [Abstract][Full Text] [Related]
28. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367 [TBL] [Abstract][Full Text] [Related]
29. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers. Abzalimov RR; Dubin PL; Kaltashov IA Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885 [TBL] [Abstract][Full Text] [Related]
30. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III. Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310 [TBL] [Abstract][Full Text] [Related]
31. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183 [TBL] [Abstract][Full Text] [Related]
32. The first component of the human complement system recognizes the active fraction of heparin. Calabrese GC; Recondo MM; Fernández de Recondo ME; Recondo EF Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):237-42. PubMed ID: 9130607 [TBL] [Abstract][Full Text] [Related]
34. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. Yokokawa K; Tahara H; Kohno M; Mandal AK; Yanagisawa M; Takeda T J Clin Invest; 1993 Oct; 92(4):2080-5. PubMed ID: 8408661 [TBL] [Abstract][Full Text] [Related]
35. [A method of assay of the anti-factor Xa activity of CY 216]. Lormeau JC; Hajjar R Pathol Biol (Paris); 1988 Apr; 36(4):335-7. PubMed ID: 2836782 [TBL] [Abstract][Full Text] [Related]
36. Effects of sera, basic fibroblast growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells. Gillis C; Jonzon B; Haegerstrand A Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1131-8. PubMed ID: 8747094 [TBL] [Abstract][Full Text] [Related]
38. [Kinetics of binding of I-125-labeled heparin and its low-molecular-weight fraction CY 222 to the endothelium in vitro]. Psuja P Acta Haematol Pol; 1987; 18(1-2):35-41. PubMed ID: 2829494 [No Abstract] [Full Text] [Related]
39. [Effect of antithrombin III on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro]. Psuja P Acta Haematol Pol; 1988; 19(3-4):143-9. PubMed ID: 2855291 [No Abstract] [Full Text] [Related]
40. [Binding of technetium 99m-labeled heparin and its low molecular weight fractions CY 216 and CY 222 to human endothelium in vitro]. Psuja P Pol Tyg Lek; 1987 Jul; 42(30):903-6. PubMed ID: 2823236 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]